Urinalysis in patients with neuromyelitis optica spectrum disorder.

Z G ChenJ HuangR FanR H WengR T ShinoharaJ R LandisY ChenYing Jiang

Published in: European journal of neurology (2019)

The urinalysis results were significantly different between NMOSD patients and MS patients. The pathophysiological changes in AQP4 antibody-positive NMOSD patients were not limited to the central nervous system.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
multiple sclerosis
ms ms
spectrum disorder